Masimo Corporation
165.93
0.36 (0.22%)
At close: Jan 14, 2025, 3:59 PM
166.95
0.61%
After-hours Jan 14, 2025, 04:00 PM EST

Masimo Corporation Revenue Breakdown

Quarter Sep 28, 2024Mar 30, 2024Dec 30, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Oct 1, 2022
Health Care Segment Revenue 343.30M 339.60M 339.90M 307.80M 281.10M 346.70M 351.80M 327.20M
Health Care Segment Revenue Growth +1.09% -0.09% +10.43% +9.50% -18.92% -1.45% +7.52% n/a

Revenue by Geography

Quarter Dec 30, 2023Dec 31, 2022Jan 1, 2022Jan 2, 2021Dec 28, 2019Dec 29, 2018Dec 30, 2017Dec 31, 2016Jan 2, 2016Jan 3, 2015Dec 28, 2013
Americas Revenue 66.40M 43.70M 41.31M 38.24M 28.71M 566.82M 506.81M 465.59M 421.63M 380.23M 361.63M
Americas Revenue Growth +51.95% +5.79% +8.03% +33.17% -94.93% +11.84% +8.85% +10.43% +10.89% +5.14% n/a
Asia Pacific Revenue 351.00M 326.80M 123.59M 103.76M 87.96M n/a n/a n/a n/a n/a n/a
Asia Pacific Revenue Growth +7.41% +164.41% +19.12% +17.96% n/a n/a n/a n/a n/a n/a n/a
Emea Revenue 571.90M 523.60M 251.84M 238.68M 183.36M n/a n/a n/a n/a n/a n/a
Emea Revenue Growth +9.22% +107.91% +5.51% +30.17% n/a n/a n/a n/a n/a n/a n/a
United States Revenue 1.06B 1.14B 822.41M 763.07M 636.37M n/a n/a n/a n/a n/a n/a
United States Revenue Growth -7.26% +38.82% +7.78% +19.91% n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 28, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Oct 1, 2022Jul 2, 2022Apr 2, 2022Jan 1, 2022Oct 2, 2021Jul 3, 2021Apr 3, 2021Jan 2, 2021Sep 26, 2020Jun 27, 2020Mar 28, 2020Dec 28, 2019Sep 28, 2019Jun 29, 2019Mar 30, 2019Dec 29, 2018Sep 29, 2018Jun 30, 2018Mar 31, 2018Dec 30, 2017Sep 30, 2017Jul 1, 2017Apr 1, 2017Dec 31, 2016Oct 1, 2016Jul 2, 2016Apr 2, 2016Jan 2, 2016Oct 3, 2015Jul 4, 2015Apr 4, 2015Jan 3, 2015
Selling, General, and Administrative Revenue 184.80M 177.50M 159.90M 159.80M 156.10M 151.70M 196.30M 185.80M 174.60M 188.30M 108.90M 104.11M 100.65M 93.83M 96.70M 90.34M 90.38M 98.46M 89.88M 81.94M 80.35M 78.16M 74.20M 74.69M 72.67M 71.42M 71.17M 78.45M 65.39M 66.38M 65.57M 69.42M 57.84M 63.89M 62.51M 70.65M 59.61M 61.67M 60.80M 61.48M
Selling, General, and Administrative Revenue Growth +4.11% +11.01% +0.06% +2.37% +2.90% -22.72% +5.65% +6.41% -7.28% +72.91% +4.60% +3.44% +7.26% -2.96% +7.04% -0.04% -8.21% +9.55% +9.68% +1.98% +2.81% +5.33% -0.65% +2.78% +1.75% +0.34% -9.27% +19.97% -1.49% +1.23% -5.55% +20.02% -9.46% +2.20% -11.52% +18.53% -3.34% +1.43% -1.11% n/a
Research and Development Revenue 48.30M 49.00M 47.80M 38.00M 46.50M 40.20M 50.50M 54.30M 53.10M 47.80M 36.12M 33.37M 35.41M 33.94M 34.51M 31.69M 28.85M 30.88M 27.24M 23.42M 24.28M 24.18M 21.41M 19.81M 19.44M 19.12M 18.60M 16.09M 15.30M 15.19M 15.37M 14.51M 15.67M 14.82M 14.37M 13.81M 14.48M 13.39M 14.93M 15.03M
Research and Development Revenue Growth -1.43% +2.51% +25.79% -18.28% +15.67% -20.40% -7.00% +2.26% +11.09% +32.34% +8.22% -5.74% +4.31% -1.65% +8.91% +9.83% -6.56% +13.35% +16.30% -3.54% +0.44% +12.89% +8.12% +1.88% +1.70% +2.77% +15.58% +5.19% +0.71% -1.14% +5.94% -7.45% +5.77% +3.15% +4.03% -4.67% +8.15% -10.28% -0.67% n/a